Related Experiment Videos

[In vitro susceptibility of dermatophyte strains to imidazole derivatives]

M Bozkurt1, S Kuştimur, M A Gürer

  • 1Gazi Universitesi, Tip Fakültesi, Dermatoloji Anabilim Dali, Oğretim Uyesi.

Mikrobiyoloji Bulteni
|January 1, 1989
PubMed

Insights

Imidazole antifungals show strong efficacy against dermatomycosis-causing fungi. Four derivatives effectively inhibited all 44 dermatophyte strains in vitro at low concentrations, demonstrating their potential for treating fungal skin infections.

Area of Science:

  • Mycology
  • Dermatology
  • Pharmacology

Background:

  • Dermatomycoses are common superficial fungal infections.
  • Imidazole derivatives are recognized for potent antimycotic activity.
  • Emerging resistance necessitates evaluating existing antifungal efficacy.

Purpose of the Study:

  • To assess the in vitro efficacy of four imidazole derivatives against clinical dermatophyte isolates.
  • To determine the minimum inhibitory concentrations (MIC) and MIC50 values for selected imidazoles.

Main Methods:

  • Isolation of 44 dermatophyte strains from outpatients diagnosed with dermatomycosis.
  • In vitro susceptibility testing of isoconazole, oxiconazole, bifonazole, and tioconazole.
  • Determination of Minimum Inhibition Concentration (MIC) and MIC50 values.

Main Results:

  • All four imidazole derivatives demonstrated efficacy against all tested dermatophyte strains.
  • Effective concentrations were found to be less than or equal to 5 micrograms/ml.
  • Variations in MIC and MIC50 values were observed among the imidazole derivatives tested.

Conclusions:

  • The studied imidazole derivatives exhibit broad-spectrum activity against common dermatophytes.
  • These agents are effective at low concentrations, supporting their clinical use in dermatomycosis.
  • Further investigation into MIC variations may guide optimal therapeutic selection.

Related Concept Videos